|
Press Releases |
|
|
|
Monday, May 18, 2015 |
|
上海醫藥與京東宣佈開啟戰略、資本、業務等層面的全面戰略合作 |
中國醫藥產品製造及分銷市場領先的一體化醫藥公司 - 上海醫藥集團股份有限公司(「上海醫藥」或「公司」,連同其附屬公司「集團」,股份代號:601607.SH;2607.HK)5月17日晚發佈公告稱,公司與北京京東世紀貿易有限公司(「京東」)簽訂戰略合作框架協議。 more info >> |
|
Shanghai Pharmaceuticals and Jingdong Announced Comprehensive Strategic Cooperation in Strategies, Capital and Businesses |
Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK), announced on 17 May that the Company has entered into a strategic cooperative framework agreement with Beijing Jingdong Century Trading Co., Ltd. ("Jingdong"). more info >> |
|
Tuesday, April 28, 2015 |
|
上海医药2015年一季度开局良好,营收、净利增势强劲 |
中国医药产品制造及分销市场领先的一体化医药公司- 上海医药集团股份有限公司(「上海医药」或「公司」,连同其附属公司「集团」,股份代号:601607.SH;2607.HK)发布2015年第一季度报告 more info >> |
|
上海醫藥2015年一季度開局良好,營收、淨利增勢強勁 |
中國醫藥產品製造及分銷市場領先的一體化醫藥公司 - 上海醫藥集團股份有限公司(「上海醫藥」或「公司」,連同其附屬公司「集團」,股份代號:601607.SH;2607.HK)發佈2015年第一季度報告 more info >> |
|
Shanghai Pharmaceuticals Shows Strong Momentum in Q1 Revenue and Net Profit |
Shanghai Pharmaceuticals Holding Co. Ltd., ("Shanghai Pharmaceuticals" or the "Company" and, together with its subsidiaries, the "Group"; stock code: 601607.SH; 02607.HK) more info >> |
|
Monday, April 13, 2015 |
|
上海医药商业分销线下布局进一步优化 「互联网+」业态潮立风口 |
2014年,上海医药(2607)分销业务达到销售收入820亿元(人民币.下同),按年增长20.57%;毛利率6.07%,按年升0.02个百分点。行业人士表示,在药品新一轮降价、新版GSP实施、医改不确定性影响加深、厂商渠道扁平化等环境挑战下,上海医药分销业务收入增长较快,毛利率保持平稳,应属不易。 more info >> |
|
上海醫藥商業分銷線下佈局進一步優化 「互聯網+」業態潮立風口 |
2014年,上海醫藥(2607)分銷業務達到銷售收入820億元(人民幣.下同),按年增長20.57%;毛利率6.07%,按年升0.02個百分點。行業人士表示,在藥品新一輪降價、新版GSP實施、醫改不確定性影響加深、廠商渠道扁平化等環境挑戰下,上海醫藥分銷業務收入增長較快,毛利率保持平穩,應屬不易。 more info >> |
|
Thursday, April 9, 2015 |
|
上海医药聚焦领域能力提升 过半重点产品增速显著 |
上海医药(2607)最新年报资料显示,2014年64个重点产品达到销售收入66.78亿元(人民币.下同),占工业销售比重60.15%,其中, 33个品种高于或等于艾美仕公司(IMS)同类品种的增长。 more info >> |
|
上海醫藥聚焦領域能力提升 過半重點產品增速顯著 |
上海醫藥(2607)最新年報資料顯示,2014年64個重點產品達到銷售收入66.78億元(人民幣.下同),佔工業銷售比重60.15%,其中, 33個品種高於或等於艾美仕公司(IMS)同類品種的增長。 more info >> |
|
Tuesday, March 31, 2015 |
|
上海医药研发投入持续增长 研发创新积蓄发力 |
上海医药(02607)在其2014年年报中披露了最新研发进展:抗体药物研发方面,「重组人肿瘤坏死因数受体突变体-Fc 融合蛋白注射液」获临床试验批件,正进行I期临床研究 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Shaping the Future of Technology with AI Everywhere Take Center Stage at the 13th Big CIO Show
May 10, 2024 20:55 HKT/SGT
|
|
|
DOCOMO to Launch "NTT DOCOMO GLOBAL" for Global Expansion
May 10, 2024 18:13 JST
|
|
|
Japan Energy Summit and Exhibition Hosts and Sponsors Demonstrate the Importance of Accelerating Decarbonisation
May 10, 2024 16:04 HKT/SGT
|
|
|
Pertamina International Shipping (PIS) Welcomes 2 VLGC Tankers to Its Fleet, Takes Top-Tier Position in ASEAN LPG Transport
May 10, 2024 16:00 HKT/SGT
|
|
|
Q2 Metals Announces Assay Results from Its 2024 Winter Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada
May 10, 2024 15:09 HKT/SGT
|
|
|
三菱重工など、電力系統の混雑緩和を実現するシステムのフィールド実証を開始
May 10, 2024 11:50: JST
|
|
|
Speculation Swirls: ESR (01821.HK) Progresses in Privatization Talks Led by Warburg Pincus
May 10, 2024 11:26 HKT/SGT
|
|
|
Release of "Fugaku-LLM" - a large language model trained on the supercomputer "Fugaku"
May 10, 2024 12:20 JST
|
|
|
InfoComm Asia 2024 "Asia's International Pro AV Exhibition" Returns to Thailand
May 10, 2024 10:30 HKT/SGT
|
|
|
好事將近?市傳ESR(01821.HK)第一大股東有意溢價最多60%提私有化
May 10, 2024 10:09 HKT/SGT
|
|
|
BLUETTI Unlocks Special Mother's Day Offerings, Perfect Gift Ideas for Moms
May 10, 2024 10:00 HKT/SGT
|
|
|
AGILON HEALTH (NYSE: AGL) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Agilon Health Investors of a Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:33 HKT/SGT
|
|
|
SSR MINING (SSRM) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies SSR Mining Investors of a Class Action Lawsuit and May 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:26 HKT/SGT
|
|
|
CHEMOURS (NYSE: CC) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and May 20, 2024 Lead Plaintiff Deadline
May 10, 2024 08:20 HKT/SGT
|
|
|
DOXIMITY (NYSE: DOCS) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Class Action Lawsuit and June 17, 2024 Lead Plaintiff Deadline
May 10, 2024 08:13 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|